Literature DB >> 1813068

Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar.

A Manni1, C Wright, H Buck.   

Abstract

The hormone dependency of the MCF-7 breast cancer cell line, while extensively tested in liquid culture, has not been previously evaluated under conditions of anchorage-independent growth in serum-free media. Using the soft agar clonogenic assay, we demonstrate that physiologically relevant concentrations of estradiol (E2), progesterone (Pg), and prolactin (PRL) similarly stimulated MCF-7 cell colony formation in the absence of serum. Addition of an anti-insulin-like growth factor-I (IGF-I) antibody inhibited E2- and Pg-stimulated growth, while PRL action was not affected. Similar results were obtained with an anti-IGF-I receptor antibody, except that its inhibitory effect on Pg-induced colony formation was modest and not statistically significant. Administration of either an anti-transforming growth factor-alpha (TGF-alpha) antibody or an anti-epidermal growth factor (EGF) receptor antibody similarly inhibited E2-stimulated MCF-7 cell growth in soft agar, while neither antibody influenced Pg or PRL effects. Addition of TGF-beta 1, -beta 2, -beta 3 similarly suppressed MCF-7 cell colony formation in a dose dependent manner to a degree comparable to that observed with 4-OH-tamoxifen (4-OH-T). Furthermore, the growth inhibitory effect of 4-OH-T was completely reversed by an anti-TGF-beta antibody. We conclude that IGFs and TGF-alpha are important mediators of E2-stimulated MCF-7 cell growth in soft agar. IGFs may also be playing a role in Pg action, while neither growth factor is involved in PRL-stimulated colony formation. Finally, TGF-beta appears to be an important mediator of antiestrogen-induced inhibition of tumor growth.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1813068     DOI: 10.1007/BF01833356

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  38 in total

1.  Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.

Authors:  C L Arteaga; C K Osborne
Journal:  Cancer Res       Date:  1989-11-15       Impact factor: 12.701

2.  Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells.

Authors:  K K Huff; C Knabbe; R Lindsey; D Kaufman; D Bronzert; M E Lippman; R B Dickson
Journal:  Mol Endocrinol       Date:  1988-03

3.  Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells.

Authors:  B W Ennis; E M Valverius; S E Bates; M E Lippman; F Bellot; R Kris; J Schlessinger; H Masui; A Goldenberg; J Mendelsohn
Journal:  Mol Endocrinol       Date:  1989-11

4.  Polyamines as mediators of estrogen action on the growth of experimental breast cancer in rats.

Authors:  A Manni; C Wright
Journal:  J Natl Cancer Inst       Date:  1984-08       Impact factor: 13.506

5.  Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.

Authors:  B A Arrick; M Korc; R Derynck
Journal:  Cancer Res       Date:  1990-01-15       Impact factor: 12.701

6.  Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture.

Authors:  R Biswas; B K Vonderhaar
Journal:  Cancer Res       Date:  1987-07-01       Impact factor: 12.701

7.  Hormonal therapies for breast cancer: can progestogens stimulate growth?

Authors:  H A Braunsberg; N G Coldham; W Wong
Journal:  Cancer Lett       Date:  1986-02       Impact factor: 8.679

8.  Role of transforming growth factor-alpha-related peptides in the autocrine/paracrine control of experimental breast cancer growth in vitro by estradiol, prolactin, and progesterone.

Authors:  A Manni; C Wright; B Badger; M Bartholomew; M Herlyn; J Mendelsohn; H Masui; L Demers
Journal:  Breast Cancer Res Treat       Date:  1990-02       Impact factor: 4.872

9.  Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines.

Authors:  D D De Leon; B Bakker; D M Wilson; R L Hintz; R G Rosenfeld
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

10.  Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide.

Authors:  U Murthy; A Basu; U Rodeck; M Herlyn; A H Ross; M Das
Journal:  Arch Biochem Biophys       Date:  1987-02-01       Impact factor: 4.013

View more
  15 in total

Review 1.  Regulation of insulin-like growth factors by antiestrogen.

Authors:  R Winston; P C Kao; D T Kiang
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

2.  Insulin analogues and carcinoma of the breast.

Authors:  P Ebeling; J A Tuominen; V A Koivisto
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

3.  Influence of antiestrogens on the migration of breast cancer cells using an in vitro wound model.

Authors:  A C Mathew; T T Rajah; G M Hurt; S M Abbas Abidi; J J Dmytryk; J T Pento
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

4.  The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.

Authors:  Diego Sisci; Pamela Maris; Maria Grazia Cesario; Wanda Anselmo; Roberta Coroniti; Giovanna Elvi Trombino; Francesco Romeo; Aurora Ferraro; Marilena Lanzino; Saveria Aquila; Marcello Maggiolini; Loredana Mauro; Catia Morelli; Sebastiano Andò
Journal:  Cell Cycle       Date:  2013-09-17       Impact factor: 4.534

5.  The effects of TGF-alpha and 17 beta-estradiol on polyphosphoinositide metabolism in MCF-7 breast cancer cells.

Authors:  R N Etindi; A Manni; J Martel
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 6.  Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?

Authors:  Antoinette R Tan; Gabriela Alexe; Michael Reiss
Journal:  Breast Cancer Res Treat       Date:  2008-10-09       Impact factor: 4.872

7.  The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study.

Authors:  J G Klijn; M P Look; H Portengen; J Alexieva-Figusch; W L van Putten; J A Foekens
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

Review 8.  William L. McGuire Memorial Symposium. Estrogen and progestin effects in human breast carcinogenesis.

Authors:  R J King
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 9.  Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.

Authors:  Katherine A Leehy; Tarah M Regan Anderson; Andrea R Daniel; Carol A Lange; Julie H Ostrander
Journal:  J Mol Endocrinol       Date:  2016-02-01       Impact factor: 5.098

10.  Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures.

Authors:  Nilgun Tasdemir; Emily A Bossart; Zheqi Li; Li Zhu; Matthew J Sikora; Kevin M Levine; Britta M Jacobsen; George C Tseng; Nancy E Davidson; Steffi Oesterreich
Journal:  Cancer Res       Date:  2018-09-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.